<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="species">human</item><item key="factors"><item><item key="2D media without EGF and insulin 2h"><item key="media">2D monolayer without EGF and insulin</item><item key="compound">4-hydroxytamoxifen</item><item key="time">2</item><item key="dose">100</item></item></item><item><item key="2D media without EGF and insulin 48h"><item key="media">2D monolayer without EGF and insulin</item><item key="compound">4-hydroxytamoxifen</item><item key="time">48</item><item key="dose">100</item></item></item><item><item key="2D media without EGF and insulin control"><item key="media">2D monolayer without EGF and insulin</item><item key="compound">none</item><item key="time">48</item><item key="dose">  </item></item></item><item><item key="2D normal media 2h"><item key="media">2D monolayer with EGF and insulin</item><item key="compound">4-hydroxytamoxifen</item><item key="time">2</item><item key="dose">100</item></item></item><item><item key="2D normal media 48h"><item key="media">2D monolayer with EGF and insulin</item><item key="compound">4-hydroxytamoxifen</item><item key="time">48</item><item key="dose">100</item></item></item><item><item key="2D normal media control"><item key="media">2D monolayer with EGF and insulin</item><item key="compound">none</item><item key="time">48</item><item key="dose">  </item></item></item><item><item key="3D normal media 2h"><item key="media">3D Matrigel culture</item><item key="compound">4-hydroxytamoxifen</item><item key="time">2</item><item key="dose">100</item></item></item><item><item key="3D normal media 48h"><item key="media">3D Matrigel culture</item><item key="compound">4-hydroxytamoxifen</item><item key="time">48</item><item key="dose">100</item></item></item><item><item key="3D normal media control"><item key="media">3D Matrigel culture</item><item key="compound">none</item><item key="time">48</item><item key="dose">  </item></item></item></item><item key="id">5199</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">4</item><item key="summary_wrapped">MCF10A MycER cells were grown either on 2D monolayer culture in the presence of complete growth medium, in the absence of EGF and insulin...</item><item key="geo_gse_id">E-MEXP-765</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">4</item><item key="sample_count">9</item><item key="tags"><item>insulin</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">transcription-profiling-by-array-of-human-mammar-3</item><item key="geo_id_plat">E-MEXP-765_A-AFFY-44</item><item key="name">Transcription profiling by array of human mammary epithelial cells grown in 2D monolayers with or without EGF and insulin, or 3D Matrigel culture, after treatment with 4-hydroxytamoxifen</item><item key="created">Sep.22, 2014</item><item key="summary">MCF10A MycER cells were grown either on 2D monolayer culture in the presence of complete growth medium, in the absence of EGF and insulin or in 3D Matrigel culture for 20 days to form acinar structures. MycER was activated with 4-hydroxytamoxifen (4-OHT) in all samples for 2 or 48 h. Control cells were treated with ethanol. The aim of the study was to explore the effect of different growth conditions on gene expression changes in response to c-Myc activation.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-765</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-765/samples/</item></data></biogps>
